Clinical Trials on Norovirus Acute Gastroenteritis in United Kingdom

Total 7540 results

ModernaTX, Inc.

Recruiting

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age

Norovirus Acute Gastroenteritis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies

Gastroenteritis Norovirus

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase I Norovirus Challenge Model

Gastroenteritis Norovirus

United States
Vaxart

Completed

Phase 1 Placebo-controlled, Randomized Trial of an Adenoviral-vector Based Norovirus Vaccine

Norovirus Gastroenteritis

United States
Vaxart

Completed

Dose-Optimization Trial of VXA-G1.1-NN in Healthy Volunteers

Norovirus Gastroenteritis

United States
National Institute of Allergy and Infectious Diseases...

Withdrawn

Phase I Study to Determine the Optimal Human Challenge Dose for a Norovirus GII.4 Challenge Stock (CIN-1)

Gastroenteritis Norovirus

United States
National Institute of Allergy and Infectious Diseases...

Completed

New Challenge Pool of Norwalk Virus Inoculum

Gastroenteritis Norovirus

United States
National Institute of Allergy and Infectious Diseases...

Completed

NNITS-Nitazoxanide for Norovirus in Transplant Patients Study

Gastroenteritis Norovirus

United States
WCCT Global
Vaxart

Completed

Evaluation of Infectivity and Illness of Norwalk GI.1 Virus Lot 001-09NV in the Human Challenge Model

Norovirus Infection

United States
Vaxart

Completed

Safety & Immunogenicity Study of Ad5 Based Oral Norovirus Vaccines (VXA-NVV-103)

Norovirus Infection

United States
LigoCyte Pharmaceuticals, Inc.

Completed

Phase 1 Norwalk Vaccine Study

Norovirus

United States
Takeda

Completed

Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in an Elderly Population

Norovirus

United States
Takeda

Completed

Serologic Assay Validation, Proficiency Testing, Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine

Healthy Participants | Norovirus

United States
Takeda

Completed

Norovirus Bivalent-Vaccine Efficacy Study

Prevention From Norovirus Infection

United States
Takeda

Completed

Safety and Immunogenicity of Norovirus Bivalent Virus-Like Particle Vaccine in Healthy Adults

Norovirus Prevention

United States
Takeda

Completed

Long-Term Immunogenicity of the Norovirus GI.1/GII.4 Bivalent Virus-like Particle (VLP) Vaccine (NoV Vaccine) in Adults

Healthy Volunteers | Norovirus

Belgium, United States
University of Surrey

Completed

Prevention of Diverticulitis by Taking a Daily Probiotic (LACTOPRoD)

Acute Diverticulitis

United Kingdom
University of Exeter
Royal Devon and Exeter NHS Foundation Trust

Completed

Complement Diagnosis of Acute Appendicitis (CDAA)

Acute Appendicitis

United Kingdom
Oxford University Hospitals NHS Trust

Withdrawn

TAP Block for Laparoscopic Appendicectomy in Adults

Acute Appendicitis

United Kingdom
Children's Hospital Medical Center, Cincinnati
Medical University of South Carolina; GlaxoSmithKline

Completed

Rotarix Vaccine Effectiveness

Acute Gastroenteritis | Rotavirus

United States
Luminex Corporation

Unknown

A Multi-Site Clinical Evaluation of the ARIES Norovirus Assay

Acute Gastroenteritis

United States
Vaxart

Completed

Immunogenicity & Safety Study of Adenovirus Type 5 (AD5) Based Oral Norovirus Vaccines (VXA-NVV-105)

Norovirus Infections

United States
Vaxart

Completed

A Phase 1, Open-label, Safety and Immunogenicity Study of an Oral Multi-dose Administration Regimen With an Adenoviral-vector Based Tablet Norovirus Vaccine (VXA-G1.1-NN) Administered to Healthy Adult Volunteers ((VXA-G1-1-NN))

Norovirus Infections

United States
Children's Hospital Medical Center, Cincinnati
LigoCyte Pharmaceuticals, Inc.

Completed

Dose Range Evaluation of Norovirus Challenge Pool (GII.4, CIN-1) (CIN-002)

Norovirus Infections

United States
Vaxart

Completed

Ph 1b: Safety & Immunogenicity of Ad5 Based Oral Norovirus Vaccine (VXA-NVV-104)

Norovirus Infections

United States
Vaxart

Active, not recruiting

A Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccines in Healthy Volunteers

Norovirus Infections

United States
Vaxart

Completed

Norovirus Challenge Study (G1-1 Challenge)

Norovirus Infections

United States
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy of Prulifloxacin Versus Placebo in Traveler's Diarrhea

Acute Gastroenteritis in Adult Travelers

United States
Children's Hospital Medical Center, Cincinnati
Mothers' Milk Bank Northeast

Terminated

Human Breastmilk in Young Children With Norovirus Infection of the Gut

Norovirus Infections

United States
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 1,Open -Label Study to Assess the Absorption, Metabolism and Excretion of 14C-OPS-2071 Following a Single Oral Dose to Healthy Male Japanese Subjects

Bacterial Enteritis

United Kingdom
AstraZeneca

Completed

An Open Label, Single Centre Mass Balance C14 Study in Patients With Acute Myeloid Leukaemia (AML)

Acute Myeloid Leukaemia

United Kingdom
Takeda

Completed

Norwalk Vaccine Study

Acute Gastroenteritis | Norwalk Virus Infection

United States
Princess Alexandra Hospital NHS Trust

Recruiting

Management of Acute Appendicitis at District General Hospital

Covid19 | Appendicitis Acute

United Kingdom
Great Ormond Street Hospital for Children NHS Foundation...
Wellcome Trust

Recruiting

Base Edited CAR T Cells Against AML: Deep Conditioning Ahead of Allogeneic Stem Cell Transplantation (CARAML)

Relapsed Acute Myeloid Leukaemia

United Kingdom
Autolus Limited

Completed

CD19 /22 CAR T Cells (AUTO3) for the Treatment of B Cell Acute Lymphoblastic Leukemia (ALL) (AMELIA)

Recurrent Childhood Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | B-cell Acute Lymphoblastic Leukemia | Refractory Childhood Acute Lymphoblastic Leukemia

United Kingdom
Imperial College London
University of Nottingham; Queen Mary University of London; Newcastle University

Enrolling by invitation

Do Probiotics Reduce The Risk Of Severe Necrotising Enterocolitis (NEC) In Infants Born Before 32 Weeks Gestation?

Enterocolitis, Necrotizing

United Kingdom
Imperial College London

Completed

i-Scan for the Detection of Helicobacter Pylori

Gastritis

United Kingdom
University College, London

Active, not recruiting

Standard Chemotherapy With or Without Nelarabine or Rituximab in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (UKALL14)

Leukemia | Mucositis | Oral Complications

United Kingdom
Cambridge University Hospitals NHS Foundation Trust
R Antakia, A Xanthis, F Georgiades, V Hudson, J Ashcroft, S Rooney, AA Singh...

Completed

MANAGEMENT OF APPENDICITIS DURING THE COVID-19 PANDEMIC (observational)

Acute Appendicitis

United Kingdom
Millennium Pharmaceuticals, Inc.

Completed

Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedolizumab

Inflammatory Bowel Disease

United Kingdom
GlaxoSmithKline
Clinical Unit at Cambridge (Addenbrooks)

Completed

A Safety and Tolerability Study of GSK2982772, in Single (in Both Fed and Fasted States) and Repeat Oral Doses in Healthy Male Subjects

Inflammatory Bowel Diseases

United Kingdom
University of Nottingham

Completed

Reduced Appetite in Crohn's Disease: The Role of the Brain in the Control of Food Intake

Crohn's Disease

United Kingdom
University College, London

Recruiting

Determining the Mechanisms of Loss of CAR T Cell Persistence (CARPERS)

Acute Lymphoblastic Leukemia, Pediatric | Acute Lymphoblastic Leukemia, in Relapse | Acute Lymphoblastic Leukemia, Adult | Acute Lymphoblastic Leukemia With Failed Remission | Acute Lymphoblastic Leukemia Not Having Achieved Remission

United Kingdom
Janssen-Cilag Ltd.

Terminated

A Study to Evaluate the Impact of Care4Today® IBD, a Smart System to Facilitate the Management of Crohn's Disease by Patients and Health Care Providers

Crohn Disease

United Kingdom
University of Birmingham
GlaxoSmithKline; University Hospital Birmingham

Completed

A Clinical Trial of Antibody GSK1070806 in the Treatment of Patients With Moderate to Severe Crohn's Disease (CDAID)

Crohn Disease

United Kingdom
NHS Greater Glasgow and Clyde
University of Glasgow

Unknown

High-impact Exercise in Adults With Crohn's Disease (IMPACT CD)

Crohn Disease

United Kingdom
University College, London
British Society of Gastrointestinal and Abdominal Radiology (BSGAR)

Recruiting

MRE Predictors of Disease Relapse After Stopping Biologics (METEOR)

Crohn's Disease

United Kingdom
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield; Crohn's & Colitis UK; Sheffield Centre for Health and...

Recruiting

Early Bowel Resection for Terminal Ileal Crohn's Disease (E-BRIC)

Crohn Disease

United Kingdom
The Leeds Teaching Hospitals NHS Trust

Completed

Anorectal Function in Perianal Crohn's Disease

Crohn Disease

United Kingdom
The Leeds Teaching Hospitals NHS Trust

Unknown

Chromoendoscopy in Inflammatory Bowel Disease

Colonoscopy

United Kingdom

Clinical Trials on Norovirus Acute Gastroenteritis in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations